Mirion Technologies (NYSE:MIR) Hits New 52-Week Low on Analyst Downgrade

Posted by Francis Steltz on Aug 1st, 2026

Mirion Technologies, Inc. (NYSE:MIR – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday after Citigroup lowered their price target on the stock from $28.00 to $24.00. Citigroup currently has a buy rating on the stock. Mirion Technologies traded as low as $14.11 and last traded at $14.5850, with a volume of 10606027 shares. The stock had previously closed at $16.79.

Other equities analysts have also issued research reports about the stock. The Goldman Sachs Group reiterated a “buy” rating and set a $23.00 price target on shares of Mirion Technologies in a report on Wednesday. Weiss Ratings downgraded Mirion Technologies from a “sell (d+)” rating to a “sell (d)” rating in a report on Monday, July 20th. B. Riley Financial lowered their target price on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a research report on Thursday. Finally, Morgan Stanley cut their target price on Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating on the stock in a report on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $26.25.

View Our Latest Stock Report on MIR

Insider Activity at Mirion Technologies

In other news, CAO Christopher A. Moore sold 8,400 shares of the stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $19.64, for a total transaction of $164,976.00. Following the completion of the sale, the chief accounting officer directly owned 22,157 shares in the company, valued at $435,163.48. This represents a 27.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 6.30% of the company’s stock.

Key Stories Impacting Mirion Technologies

Here are the key news stories impacting Mirion Technologies this week:

Positive Sentiment: Mirion maintained its 2026 outlook and expects second-half organic revenue growth of approximately 7.5% to 11.2%, alongside adjusted EBITDA margins of 27% to 29%. This indicates management still expects solid underlying growth and profitability improvement. Mirion maintains 2026 outlook
Positive Sentiment: Citigroup lowered its price target to $24 from $28 but retained a “buy” rating, implying substantial upside from the current trading level. B. Riley likewise maintained a “buy” rating while reducing its target to $27 from $29. Citigroup price target update
Neutral Sentiment: Mirion’s latest quarterly results showed adjusted earnings of $0.12 per share, ahead of the $0.10 consensus estimate, while revenue rose 19.7% year over year to $266.8 million but fell slightly short of expectations. The mixed results highlight strong growth but limited near-term execution upside. Mirion Q2 2026 earnings call summary
Negative Sentiment: Northland Securities reduced its Q3 2026 EPS estimate to $0.12 from $0.14 and lowered its FY2027 forecast to $0.71 from $0.72. Although the cuts are modest, they signal softer expectations for near-term earnings growth and may contribute to selling pressure.

Institutional Trading of Mirion Technologies

A number of large investors have recently bought and sold shares of the business. UBS Group AG raised its position in shares of Mirion Technologies by 181.4% in the 3rd quarter. UBS Group AG now owns 4,796,833 shares of the company’s stock worth $111,574,000 after acquiring an additional 3,092,136 shares in the last quarter. Maverick Capital Ltd. bought a new stake in shares of Mirion Technologies during the 1st quarter valued at about $49,261,000. TCW Group Inc. acquired a new stake in Mirion Technologies during the fourth quarter worth approximately $57,439,000. Invesco Ltd. grew its stake in Mirion Technologies by 713.2% during the second quarter. Invesco Ltd. now owns 2,617,252 shares of the company’s stock worth $56,349,000 after purchasing an additional 2,295,414 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in Mirion Technologies by 126.1% in the fourth quarter. Bank of New York Mellon Corp now owns 3,076,945 shares of the company’s stock worth $72,062,000 after purchasing an additional 1,716,020 shares in the last quarter. 78.51% of the stock is currently owned by institutional investors and hedge funds.

Mirion Technologies Stock Performance

The company has a debt-to-equity ratio of 0.64, a current ratio of 3.20 and a quick ratio of 2.63. The stock has a fifty day simple moving average of $17.09 and a two-hundred day simple moving average of $19.72. The firm has a market capitalization of $3.75 billion, a P/E ratio of 149.89 and a beta of 1.03.

Mirion Technologies (NYSE:MIR – Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.02. The firm had revenue of $266.80 million for the quarter, compared to analysts’ expectations of $269.32 million. Mirion Technologies had a return on equity of 6.59% and a net margin of 2.39%.The company’s revenue for the quarter was up 19.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.11 EPS. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. On average, research analysts predict that Mirion Technologies, Inc. will post 0.54 EPS for the current year.

About Mirion Technologies

(Get Free Report)

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.